Michael Brennan to Cohort Studies
This is a "connection" page, showing publications Michael Brennan has written about Cohort Studies.
Connection Strength
0.370
-
Likar-Manookin K, Stewart C, Al-Hashimi I, Curtis W, Berg K, Cherian K, Lockhart PB, Brennan MT. Prevalence of oral lesions of autoimmune etiology in patients with primary Sjogren's syndrome. Oral Dis. 2013 Sep; 19(6):598-603.
Score: 0.078
-
Rouleau TS, Shychuk AJ, Kayastha J, Lockhart PB, Nussbaum ML, Brennan MT. A retrospective, cohort study of the prevalence and risk factors of oral burning in patients with dry mouth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Jun; 111(6):720-5.
Score: 0.069
-
Brennan MT, Hong C, Furney SL, Fox PC, Lockhart PB. Utility of an international normalized ratio testing device in a hospital-based dental practice. J Am Dent Assoc. 2008 Jun; 139(6):697-703.
Score: 0.057
-
Lin A, Helgeson ES, Treister NS, Schmidt BL, Patton LL, Elting LS, Lalla RV, Brennan MT, Sollecito TP. The impact of head and neck radiotherapy on salivary flow and quality of life: Results of the ORARAD study. Oral Oncol. 2022 Apr; 127:105783.
Score: 0.037
-
Treister NS, Brennan MT, Sollecito TP, Schmidt BL, Patton LL, Mitchell R, Haddad RI, Tishler RB, Lin A, Shadick R, Hodges JS, Lalla RV. Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad). Cancer. 2022 02 01; 128(3):487-496.
Score: 0.036
-
Lalla RV, Long-Simpson L, Hodges JS, Treister N, Sollecito T, Schmidt B, Patton LL, Brennan MT. Clinical registry of dental outcomes in head and neck cancer patients (OraRad): rationale, methods, and recruitment considerations. BMC Oral Health. 2017 Feb 27; 17(1):59.
Score: 0.026
-
Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM, Lessard CJ, Vaughn SE, Marion M, Weirauch MT, Namjou B, Adler A, Rasmussen A, Glenn S, Montgomery CG, Hirschfield GM, Xie G, Coltescu C, Amos C, Li H, Ice JA, Nath SK, Mariette X, Bowman S, Rischmueller M, Lester S, Brun JG, Gøransson LG, Harboe E, Omdal R, Cunninghame-Graham DS, Vyse T, Miceli-Richard C, Brennan MT, Lessard JA, Wahren-Herlenius M, Kvarnström M, Illei GG, Witte T, Jonsson R, Eriksson P, Nordmark G, Ng WF, Anaya JM, Rhodus NL, Segal BM, Merrill JT, James JA, Guthridge JM, Scofield RH, Alarcon-Riquelme M, Bae SC, Boackle SA, Criswell LA, Gilkeson G, Kamen DL, Jacob CO, Kimberly R, Brown E, Edberg J, Alarcón GS, Reveille JD, Vilá LM, Petri M, Ramsey-Goldman R, Freedman BI, Niewold T, Stevens AM, Tsao BP, Ying J, Mayes MD, Gorlova OY, Wakeland W, Radstake T, Martin E, Martin J, Siminovitch K, Moser Sivils KL, Gaffney PM, Langefeld CD, Harley JB, Kaufman KM. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Hum Mol Genet. 2015 Jan 15; 24(2):582-96.
Score: 0.022
-
Napeñas JJ, Hong CH, Kempter E, Brennan MT, Furney SL, Lockhart PB. Selective serotonin reuptake inhibitors and oral bleeding complications after invasive dental treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Oct; 112(4):463-7.
Score: 0.018
-
Napeñas JJ, Hong CH, Brennan MT, Furney SL, Fox PC, Lockhart PB. The frequency of bleeding complications after invasive dental treatment in patients receiving single and dual antiplatelet therapy. J Am Dent Assoc. 2009 Jun; 140(6):690-5.
Score: 0.015
-
Valerin MA, Napeñas JJ, Brennan MT, Fox PC, Lockhart PB. Modified Child-Pugh score as a marker for postoperative bleeding from invasive dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jul; 104(1):56-60.
Score: 0.013